Puma Biotechnology Inc
NASDAQ:PBYI

Watchlist Manager
Puma Biotechnology Inc Logo
Puma Biotechnology Inc
NASDAQ:PBYI
Watchlist
Price: 3.04 USD 2.36%
Market Cap: 149.1m USD
Have any thoughts about
Puma Biotechnology Inc?
Write Note

Intrinsic Value

The intrinsic value of one PBYI stock under the Base Case scenario is 5.41 USD. Compared to the current market price of 3.04 USD, Puma Biotechnology Inc is Undervalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PBYI Intrinsic Value
5.41 USD
Undervaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Puma Biotechnology Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PBYI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PBYI?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Puma Biotechnology Inc

Provide an overview of the primary business activities
of Puma Biotechnology Inc.

What unique competitive advantages
does Puma Biotechnology Inc hold over its rivals?

What risks and challenges
does Puma Biotechnology Inc face in the near future?

Summarize the latest earnings call
of Puma Biotechnology Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Puma Biotechnology Inc.

Provide P/S
for Puma Biotechnology Inc.

Provide P/E
for Puma Biotechnology Inc.

Provide P/OCF
for Puma Biotechnology Inc.

Provide P/FCFE
for Puma Biotechnology Inc.

Provide P/B
for Puma Biotechnology Inc.

Provide EV/S
for Puma Biotechnology Inc.

Provide EV/GP
for Puma Biotechnology Inc.

Provide EV/EBITDA
for Puma Biotechnology Inc.

Provide EV/EBIT
for Puma Biotechnology Inc.

Provide EV/OCF
for Puma Biotechnology Inc.

Provide EV/FCFF
for Puma Biotechnology Inc.

Provide EV/IC
for Puma Biotechnology Inc.

Show me price targets
for Puma Biotechnology Inc made by professional analysts.

What are the Revenue projections
for Puma Biotechnology Inc?

How accurate were the past Revenue estimates
for Puma Biotechnology Inc?

What are the Net Income projections
for Puma Biotechnology Inc?

How accurate were the past Net Income estimates
for Puma Biotechnology Inc?

What are the EPS projections
for Puma Biotechnology Inc?

How accurate were the past EPS estimates
for Puma Biotechnology Inc?

What are the EBIT projections
for Puma Biotechnology Inc?

How accurate were the past EBIT estimates
for Puma Biotechnology Inc?

Compare the revenue forecasts
for Puma Biotechnology Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Puma Biotechnology Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Puma Biotechnology Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Puma Biotechnology Inc compared to its peers.

Compare the P/E ratios
of Puma Biotechnology Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Puma Biotechnology Inc with its peers.

Analyze the financial leverage
of Puma Biotechnology Inc compared to its main competitors.

Show all profitability ratios
for Puma Biotechnology Inc.

Provide ROE
for Puma Biotechnology Inc.

Provide ROA
for Puma Biotechnology Inc.

Provide ROIC
for Puma Biotechnology Inc.

Provide ROCE
for Puma Biotechnology Inc.

Provide Gross Margin
for Puma Biotechnology Inc.

Provide Operating Margin
for Puma Biotechnology Inc.

Provide Net Margin
for Puma Biotechnology Inc.

Provide FCF Margin
for Puma Biotechnology Inc.

Show all solvency ratios
for Puma Biotechnology Inc.

Provide D/E Ratio
for Puma Biotechnology Inc.

Provide D/A Ratio
for Puma Biotechnology Inc.

Provide Interest Coverage Ratio
for Puma Biotechnology Inc.

Provide Altman Z-Score Ratio
for Puma Biotechnology Inc.

Provide Quick Ratio
for Puma Biotechnology Inc.

Provide Current Ratio
for Puma Biotechnology Inc.

Provide Cash Ratio
for Puma Biotechnology Inc.

What is the historical Revenue growth
over the last 5 years for Puma Biotechnology Inc?

What is the historical Net Income growth
over the last 5 years for Puma Biotechnology Inc?

What is the current Free Cash Flow
of Puma Biotechnology Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Puma Biotechnology Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Puma Biotechnology Inc

Current Assets 137.7m
Cash & Short-Term Investments 96.8m
Receivables 28.1m
Other Current Assets 12.8m
Non-Current Assets 67.3m
PP&E 6.9m
Intangibles 56m
Other Non-Current Assets 4.4m
Current Liabilities 104.3m
Accounts Payable 13.5m
Accrued Liabilities 44.2m
Other Current Liabilities 46.6m
Non-Current Liabilities 52.2m
Long-Term Debt 43.7m
Other Non-Current Liabilities 8.5m
Efficiency

Earnings Waterfall
Puma Biotechnology Inc

Revenue
219.1m USD
Cost of Revenue
-59m USD
Gross Profit
160.1m USD
Operating Expenses
-141.2m USD
Operating Income
18.9m USD
Other Expenses
-10.2m USD
Net Income
8.7m USD

Free Cash Flow Analysis
Puma Biotechnology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PBYI Profitability Score
Profitability Due Diligence

Puma Biotechnology Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
ROIC is Increasing
Positive ROE
57/100
Profitability
Score

Puma Biotechnology Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

PBYI Solvency Score
Solvency Due Diligence

Puma Biotechnology Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Long-Term Solvency
Low D/E
35/100
Solvency
Score

Puma Biotechnology Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PBYI Price Targets Summary
Puma Biotechnology Inc

Wall Street analysts forecast PBYI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PBYI is 4.42 USD with a low forecast of 2.02 USD and a high forecast of 7.35 USD.

Lowest
Price Target
2.02 USD
34% Downside
Average
Price Target
4.42 USD
45% Upside
Highest
Price Target
7.35 USD
142% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PBYI?

Click here to dive deeper.

Dividends

Puma Biotechnology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PBYI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Puma Biotechnology Inc Logo
Puma Biotechnology Inc

Country

United States of America

Industry

Biotechnology

Market Cap

145.6m USD

Dividend Yield

0%

Description

Puma Biotechnology, Inc. is a biopharmaceutical company. The company is headquartered in Los Angeles, California and currently employs 196 full-time employees. The company went IPO on 2012-03-21. The firm is focused on the development and commercialization of products to enhance cancer care. The firm's lead product is NERLYNX, an oral version of neratinib, which is a potent irreversible tyrosine kinase inhibitor (TKI) that blocks signal transduction through the human epidermal growth factor receptors, HER1, HER2 and HER4. The company is primarily focused on the development and commercialization of the oral version of neratinib, and its advanced drug candidates are directed at the treatment of HER2-positive breast cancer and HER2 mutated cancers. Its other products include PB272 (neratinib, intravenous), PB357, and certain related compounds. Its neratinib has clinical application in the treatment of several other cancers as well, including other tumor types that over-express or have a mutation in HER2 or epidermal growth factor receptor (EGFR), such as breast cancer, cervical cancer, lung cancer, or other solid tumors.

Contact

CALIFORNIA
Los Angeles
10880 Wilshire Blvd Ste 2150
+14242486500.0
www.pumabiotechnology.com

IPO

2012-03-21

Employees

196

Officers

Founder, Chairman, President, CEO & Secretary
Mr. Alan H. Auerbach
CFO & Principal Accounting Officer
Mr. Maximo F. Nougues
Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer
Mr. Douglas Hunt B.Sc., FRAPS
Chief Commercial Officer
Mr. Jeffrey Jerome Ludwig
Senior Director of Investor Relations
Mr. Mariann Ohanesian
Senior Vice President of Clinical Development
Dr. Bo H. Chao

See Also

Discover More
What is the Intrinsic Value of one PBYI stock?

The intrinsic value of one PBYI stock under the Base Case scenario is 5.41 USD.

Is PBYI stock undervalued or overvalued?

Compared to the current market price of 3.04 USD, Puma Biotechnology Inc is Undervalued by 44%.

Back to Top